Literature DB >> 14583300

The role of surgery in hemoptysis caused by thoracic actinomycosis; a forgotten disease.

Ming-Shian Lu1, Hui-Ping Liu, Chi-Hsiao Yeh, Yi-Cheng Wu, Yun-Hen Liu, Ming-Ju Hsieh, Tzu-Ping Chen.   

Abstract

OBJECTIVE: Thoracic actinomycosis is a relatively uncommon anaerobic infection caused by Actinomyces israelii. Rarely, it may be complicated by an unusual but significant hemoptysis manifestation. We describe our experiences of surgical treatment for hemoptysis in patients with pulmonary actinomycosis.
METHODS: From 1984 to 2002, 14 patients with thoracic actinomycosis and hemoptysis were diagnosed after thoracotomy. There were 11 male and three female patients with a mean age of 53.6 years. They all had non-specific symptoms and radiographic findings, and no case was an accurate diagnosis made at the time of hospital admission, including echo-guide aspiration, serial bronchoscopic biopsy and computed tomography biopsy. The indications of surgical intervention in our patients were for treating complications such as hemoptysis, chronic sinus discharge, or empyema, also limited to diagnostic purposes. Preoperative embolization was performed in seven cases; however, none was successful.
RESULTS: Among the 14 patients, all the lesions were unilateral. The disease was confined to the lung in all patients; and chest wall involvement in one patient. The surgical procedures included were as follows: pneumonectomy (n=1), bilobectomy (n=1), lobectomy (n=10), wedge resection (n=2), and lung lesion with concomitant chest wall resection and chest wall reconstruction (n=1). Mean intraoperative and postoperative blood loss within the first 24 h was 192.3 ml, and five patients required blood transfusion. All of the specimens from the lesion site showed histological evidence of Actinomyces infection. All patients regularly took 12 million units per day of intravenous crystalline penicillin G during their hospitalization, and oral procaine penicillin for up to 2 months. During the follow-up, all patients had an uneventful postoperative course.
CONCLUSIONS: A high index of suspicion for this disease is advised for the surgeon engaged in the treatment of hemoptysis. Surgical resection of pulmonary actinomycosis is effective in preventing recurrence of hemoptysis. After diagnosis, it is treated using penicillin chemotherapy for at least 2 months.

Entities:  

Mesh:

Year:  2003        PMID: 14583300     DOI: 10.1016/s1010-7940(03)00515-3

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  9 in total

1.  Pulmonary actinomycosis in a male patient with a tracheal bronchus.

Authors:  Cecilia T Costiniuk; Nha Voduc; Carolina de Souza
Journal:  Can Respir J       Date:  2011 Mar-Apr       Impact factor: 2.409

2.  Treatment of thoracic actinomycosis: A retrospective analysis of 40 patients.

Authors:  Jae-Uk Song; Hye Yun Park; Kyeongman Jeon; Sang-Won Um; O Jung Kwon; Won-Jung Koh
Journal:  Ann Thorac Med       Date:  2010-04       Impact factor: 2.219

3.  Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen.

Authors:  Janine Reichenbach; Uri Lopatin; Nizar Mahlaoui; Bojana Beovic; Ulrich Siler; Reinhard Zbinden; Reinhard A Seger; Louise Galmiche; Nicole Brousse; Samer Kayal; Tayfun Güngör; Stéphane Blanche; Steven M Holland
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

4.  Thoracic actinomycosis in an adolescent mimicking chest wall tumor or pulmonary tuberculosis.

Authors:  V H W Yeung; Q H Y Wong; N S Y Chao; M W Y Leung; W K Kwok
Journal:  Pediatr Surg Int       Date:  2008-04-12       Impact factor: 1.827

5.  Pulmonary actinomycosis.

Authors:  Solmaz Celebi; Betul Sevinir; Ozlem Saraydaroglu; Arif Gurpinar; Mustafa Hacimustafaoglu
Journal:  Indian J Pediatr       Date:  2009-01-05       Impact factor: 1.967

6.  Severe Hemoptysis Associated with Bacterial Pulmonary Infection: Clinical Features, Significance of Parenchymal Necrosis, and Outcome.

Authors:  Guillaume Carteaux; Damien Contou; Guillaume Voiriot; Antoine Khalil; Marie-France Carette; Martine Antoine; Antoine Parrot; Muriel Fartoukh
Journal:  Lung       Date:  2017-10-12       Impact factor: 2.584

7.  Pulmonary actinomycosis mimicking lung cancer on positron emission tomography.

Authors:  Hayoung Choi; Hyun Lee; Suk Hyeon Jeong; Sang-Won Um; O Jung Kown; Hojoong Kim
Journal:  Ann Thorac Med       Date:  2017 Apr-Jun       Impact factor: 2.219

8.  Pulmonary Actinomycosis Revealed by a Solitary Pulmonary Nodule.

Authors:  Deghdegh Khaled; Terra Besma; Amoura Kamel; Benali Rachid
Journal:  Case Rep Pulmonol       Date:  2022-02-16

9.  Pulmonary actinomycosis during the first decade of 21st century: cases of 94 patients.

Authors:  So Ri Kim; Lae Young Jung; In-Jae Oh; Young-Chul Kim; Kyeong-Cheol Shin; Min Ki Lee; Sei-Hoon Yang; Hee Sun Park; Mi-Kyung Kim; Jin Young Kwak; Soo-Jung Um; Seung Won Ra; Woo Jin Kim; Seungsoo Kim; Eu-Gene Choi; Yong Chul Lee
Journal:  BMC Infect Dis       Date:  2013-05-14       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.